There are many kinds of targeted drugs, such as anti-angiogenic ones and epidermal growth factor receptor inhibitors for lung cancer. In addition, there are anti-CD20 monoclonal antibodies, proteasome inhibitors, etc. The cost of different targeted drugs varies. For example, the drug Apatinib, an anti-angiogenic agent for malignant tumors, costs about$4,000-5,000 per month. The cost of gefitinib, a targeted drug for lung cancer, is also around$5,000 per month for a domestic drug. For Imatinib, a targeted drug for chronic granulocytic leukemia, the cost of the domestic drug is around$1,600 per month. Bortezomib, a proteasome inhibitor for multiple myeloma, costs more than$10,000 per cycle. Also, for now, most of the targeted drugs are covered by reimbursement.